Induction by Dopamine D1 Receptor Agonist ABT-431 of Dyskinesia Similar to Levodopa in Patients With Parkinson Disease
Archives of Neurology2001Vol. 58(2), pp. 249–249
Citations Over TimeTop 10% of 2001 papers
Olivier Rascol, John G. Nutt, Olivier Blin, Christopher G. Goetz, Joel M. Trugman, C Soubrouillard, J H Carter, L. J. Currie, Nelly Fabre, Claire Thalamas, William J. Giardina, Stephen Wright
Abstract
Dopamine D(1) agonists can induce a full antiparkinsonian response but do not support previous hypotheses suggesting that D(1) agonists are more or less likely to produce dyskinesias than levodopa.
Related Papers
- Clinical pharmacology of levodopa-induced dyskinesia.(2000)
- → Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease(2013)9 cited
- → Risk factors for levodopa-induced dyskinesia in Parkinson’s disease patients(2016)1 cited
- → Levodopa-responsive retrocollis on the background of choreic dyskinesia(2019)1 cited